<p>(a) anti-leukemic drugs were selected using three approaches: kinase inhibitor library screens, correlation analysis, and literature survey. (b) Dose responses of single agent and pair-wise analysis with a fixed dose of imatinib (pairs and triplets) were performed. (c) The drug combinations were optimized using iterative search algorithm (d) The optimal drug combinations were validated with primary patient cells.</p

    Similar works

    Full text


    Available Versions